Company led drug alert – Paclitaxel 6 mg/ml concentrate for solution for infusion (25ml vials)
Read the official alert on GOV.UK — MedRegWatch re-presents it; GOV.UK is the authoritative source.
| Type | Medicines recall/notification |
|---|---|
| Issued | 19 Dec 2019 |
| Product licences | PL 04515/0159 |
CLDA Number
CLDA (19)A/07
MDR Number
MDR 096-12/19
Company Name
Hospira UK Limited (Pfizer)
Product Description
Paclitaxel 6 mg/ml concentrate for solution for infusion (25ml vials)
PL 04515/0159
Batch Number/Expiry
- Batch number: F016842AD
- Expiry date: 29 Feb 2020
- Pack size: 1 x 25ml
- First distributed: 31 July 2018
Brief Description of Problem
Hospira UK Limited is recalling the above batch of the Paclitaxel 6 mg/ml concentrate for solution for infusion (150mg/25ml) as a precautionary measure.
This is due to a manufacturing issue which could potentially have resulted in a loss of sterility assurance.
Company Contact for medical information enquiries
Pfizer Medical Information, Tel. 01304 616161
Company Contact for stock enquiries
Remaining stock of this batch should be quarantined and returned to the original supplier for credit.
For stock enquiries, please contact your original supplier or local branch of Alliance Healthcare.
Hold any of these licences?Check all your PL numbers against the full archive in one paste — or join the waitlist for automatic matching and an inspection-ready recall register.